We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AENA:BMEAena SME SA Analysis

Data as of 2026-06-14 - not real-time

MX$498.26

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

AENA is trading at its 52‑week low of 498.26 MXN, right on the identified support level and below its 20‑day (509.46) and 50‑day (521.94) SMAs, signaling a short‑term price weakness. However, the RSI is ultra‑low at 2.5, suggesting the stock is deeply oversold, while the MACD remains bearish but the histogram is narrowing, hinting at a possible technical reversal. Volume trends are decreasing and 30‑day volatility is elevated at ~18%, yet the computed beta is essentially zero, indicating minimal market‑wide price swings.
Fundamentally, AENA delivers exceptional profitability with a gross margin of 80% and an operating margin above 30%, while ROE stands at 24% and ROA at 10%. The PE ratio of 17.3 is well below the industry average of 30.6, and the dividend yield of 4.46% is supported by a 68% payout ratio and robust free cash flow. Leverage is a concern (debt‑to‑equity ~83%), but the company’s cash position and cash‑flow generation provide a cushion. Overall, the stock appears undervalued with strong cash returns and a resilient business model.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI at 2.5 indicates extreme oversold condition
  • Price is at technical support of 498.26 MXN
  • Decreasing volume and elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong profitability margins and high ROE
  • Undervalued relative to industry PE (17.3 vs 30.6)
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistent free cash flow supporting dividend sustainability
  • Low market beta suggesting defensive characteristics
  • Diversified geographic footprint reducing single‑country exposure

Key Metrics & Analysis

Financial Health

Revenue Growth11.80%
Profit Margin33.51%
P/E Ratio17.3
ROE24.40%
ROA10.16%
Debt/Equity83.47
P/B Ratio3.9
Op. Cash FlowMX$2.9B
Free Cash FlowMX$1.4B
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI2.5
SupportMX$498.26
ResistanceMX$530.26
MA 20MX$509.46
MA 50MX$521.94
MA 200MX$509.39
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueMX$17.37
GradeUndervalued
TypeBlend
Dividend Yield4.46%

Risk Assessment

Beta0.01
Volatility18.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.